Skip to content

´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2.

´Sit Less, Move More' at Work: Impact of a mHealth Intervention on the Glycaemic Control and Anthropometric Profile of Office Employees With Diabetes Type 2. A Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04092738
Acronym
Walk@Work
Enrollment
368
Registered
2019-09-17
Start date
2019-03-04
Completion date
2021-09-30
Last updated
2019-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type II

Keywords

mHealth, Physical Activity, Glucose, Blood, Glycated Hemoglobin A1c, Health-Related Quality Of Life, Quality of Life, Triglycerides, HDL Cholesterol, LDL Cholesterol, Blood Pressure, Arterial, Presenteeism, Sitting time, Sedentary Behaviour, Workplace

Brief summary

The objective of the study is measuring the impact of a ´sit less, move more' mHealth intervention at work on the glycaemic control and anthropometric profile of office employees with diabetes type 2 (DT2) at short, mid and long term.

Detailed description

A double-blind randomized controlled trial. Seven Primary Care Centers from Spain (n=5 Catalonia, n=2 Madrid), 2 hospitals (n=1 Catalonia, n=1 Madrid) and 2 companies (occupational health services; n=1 public, n=1 private) will participate in the study. In each center, physicians, nurses, endocrinologists and occupational physicians will recruit patients with DT2 who spend at least 55% of their working hours doing desk-based tasks (OSPAQ) and have a cellphone. Following the CONSORT Statement (2010), volunteers will be randomized into a control (CG) or intervention group (IG) by the research team using a computer program to generate the random sequence. 184 individuals are needed in each group. Main variables: fasting glucose levels, HbA1c, weight, height, BMI, waist circumference. Occupational sitting time and sitting time breaks will be measured using ActivPAL devices. Other variables: physical activity (IPAQ short), quality of life (EuroQool), presenteeism (WLQ), triglycerides, total cholesterol (LDL and HDL), blood pressure and sociodemographic variables. Intervention: A mHealth program (13 wks) will progressively replace occupational sitting time with light physical activities. Participants from the CG will receive usual care. Multivariate analysis will assess changes over time (post intervention and at 6 months follow up) in the dependent variables; looking at differences between groups. Intention to treat will be applied.

Interventions

BEHAVIORALWalk@WorkApp-Diab

The intervention (Walk@WorkApp-Diab), based on an mHealth program, consists on replacing sedentary job tasks for active ones, during 13 weeks. The intervention group will download the mHealth program into their personal cellphones

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Consorci Hospitalari de Vic
CollaboratorOTHER
Institut Català de la Salut
CollaboratorOTHER
University of Vic - Central University of Catalonia
CollaboratorOTHER
Puerta de Hierro University Hospital
CollaboratorOTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomized controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* DM2 diagnosed office employees according to international criteria. * Doing sedentary tasks during at least a 55% of their daily work schedule (according to the Occupational Sedentary and Physical Activity Questionnaire: OSPAQ \>55%). * Having a cellphone . * Having a minimum work contract of 18.5 hours per week. * Being able to get up from the chair or to walk by themselves (without any help).

Exclusion criteria

* Not having a cellphone. * Having some pathology/disability/injury which changes their ability and capacity to walk or getting up from the chair. * Doing less than a 55% of the daily tasks in a sitting position according to the OSPAQ questionnaire.

Design outcomes

Primary

MeasureTime frameDescription
Change in Waist circumferenceThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finishedWaist circumference in centimetres using a flexible steel tape (Seca 203)
Change in Body Mass IndexThree measurement points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after intervention has finished.Weight and height will be combined to report Body Mass Index (kg/m2)
Change in Fasting glucose levelsTwo measurement points: (a) Before the intervention starts, (b) at 6 months after intervention has finishedBlood tests
Change in heightThree measurement points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after intervention has finished.Body height in metres (electronic scale-Seca 899/217)
Change in weightThree measurement points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after intervention has finished.Body weight in kilograms (electronic scale-Seca 899/217)
Change in concentration of HbA1cTwo measurement points: (a) before the intervention starts, (b) at 6 months after intervention has finished.Blood tests

Secondary

MeasureTime frameDescription
Change in objective occupational physical activityThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.Minutes/day spent doing light and moderate-to-vigorous physical activity (ActivPal device)
Change in objective Occupational sedentary behaviourThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.Total sitting time (minutes/day), sedendary bouts (daily time spent sitting on less than 20 minutes periods, between 20-60 minutes periods, more than 60 minutes period (ActivPal device)
Change in subjective domain-specific sedentary behaviourThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.Workforce Sitting Questionnaire (daily time spent sitting watching TV, working, at home, as transport and for leisure during working days and nonworking days (minutes/day)
Change in subjective occupational physical activityThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.Minutes/day walking, doing moderate and vigorous physical activity (International Physical Activity Questionnaire, IPAQ)

Other

MeasureTime frameDescription
Change in health-related quality of lifeThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.EQ-5d-3L. Scores range from 0 to 100 (0 describes the worse health you can imagine while 100 describes the best health you can imagine)
Sociodemographic variables (age, gender, socio economic status)One measurment point: (a) before the intervention.Questionnaire
Change in blood pressureThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.Digital automatic blood pressure monitor-Omron M7 (mmHg)
Change in total cholesterol levelsTwo measurement points: (a) Before the intervention starts, (b) at 6 months after the intervention has finished.Blood tests (mg/dL)
Change in concentration of TriglyceridesTwo measurement points: (a) Before the intervention starts, (b) at 6 months after the intervention has finished.Blood tests (mg/dL)
Change in Presenteeism levelsThree measurment points: (a) before the intervention, (b) immediately after the intervention, (c) at 6 months after the intervention has finished.Work Limitations Questionnaire. Scores range from 0 to 100 (0 describes that your health dones not limit you at all in doing thw work tasks, while 100 describes your health limits you a lot your work tasks)

Countries

Spain

Contacts

Primary ContactAnna Puig-Ribera
annam.puig@uvic.cat+34 619352497
Backup ContactFrancesc Alos Colomer
cesc.alos@gmail.com+34 618429646

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026